These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 7876549

  • 21. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
    Del Giudice G, Tougne C, Louis JA, Lambert PH, Bianchi E, Bonelli F, Chiappinelli L, Pessi A.
    Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
    [Abstract] [Full Text] [Related]

  • 22. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK, Farah D, Misra-Bhattacharya S, Bajpai P, Agarwal A, Mohammad O.
    Vaccine; 2006 Feb 13; 24(7):948-56. PubMed ID: 16168527
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM, Majarian WR, Young JF, Daly TM, Long CA.
    J Immunol; 1989 Oct 15; 143(8):2670-6. PubMed ID: 2477452
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
    Calvo PA, Daly TM, Long CA.
    Exp Parasitol; 1996 Jan 15; 82(1):54-64. PubMed ID: 8617331
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI, Sedegah M, Rogers WO, Jones TR, Sacci J, Witney A, Carucci DJ, Kumar N, Hoffman SL.
    Infect Immun; 2001 Jun 15; 69(6):3897-905. PubMed ID: 11349057
    [Abstract] [Full Text] [Related]

  • 38. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
    Reed RC, Louis-Wileman V, Cosmai EV, Fang S, Jue DL, Wohlhueter RM, Hunter RL, Lal AA.
    Vaccine; 1997 Apr 15; 15(5):482-8. PubMed ID: 9160515
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
    Ophorst OJ, Radosević K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsmit J, Tsuji M.
    Infect Immun; 2006 Jan 15; 74(1):313-20. PubMed ID: 16368986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.